跳转至内容
Merck
CN

主要文件

查看所有文档

120871

对苯二甲酰氯

≥99%, flakes

别名:

Terephthalic acid chloride, Terephthaloyl dichloride

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
C6H4-1,4-(COCl)2
化学文摘社编号:
100-20-9
分子量:
203.02
NACRES:
NA.22
PubChem Substance ID:
24847435
eCl@ss:
39050525
UNSPSC Code:
12352100
EC Number:
202-829-5
MDL number:
MFCD00000693
Beilstein/REAXYS Number:
607796
Assay:
≥99%
Form:
flakes
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

vapor density

7 (vs air)

Quality Level

200

vapor pressure

0.02 mmHg ( 25 °C)

assay

≥99%

form

flakes

bp

266 °C (lit.)

mp

79-81 °C (lit.)

solubility

ethanol: soluble 100 mg/mL, clear, colorless

functional group

acyl chloride

SMILES string

ClC(=O)c1ccc(cc1)C(Cl)=O

InChI

1S/C8H4Cl2O2/c9-7(11)5-1-2-6(4-3-5)8(10)12/h1-4H

InChI key

LXEJRKJRKIFVNY-UHFFFAOYSA-N

General description

对苯二甲酰氯是一种源自对苯二甲酸的高反应性酰氯。它在聚合物合成中用作交联剂。对苯二甲酰氯与双官能团α,ω-二氨基聚苯乙烯发生缩合反应，沿着聚合物主链生成含有酰胺键的扩链聚苯乙烯。它与牛血清白蛋白发生界面反应，形成交联薄膜。

Application

对苯二甲酰氯通过环状取代 双 （4-羟基苯基）对苯二甲酸酯的二氰酸酯化合物进行热环三聚反应，以用于合成液晶热固性化合物 。

Legal Information

DuPont 产品

pictograms

Skull and crossbonesCorrosion
GHS06,GHS05

signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Eye Dam. 1 - Skin Corr. 1A - STOT SE 3

target_organs

Respiratory system

存储类别

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 1

flash_point_f

356.0 °F - closed cup

flash_point_c

180 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

法规信息

危险化学品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
STBG9848
STBG6058V
STBG5521V
STBF9626V
STBF8978V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

有机和有机无机杂化聚合物的分子层沉积

近十年来出现了原子层沉积（ALD）技术以满足各种需求，包括半导体器件小型化、多孔结构上的保形沉积和纳米颗粒涂层。ALD基于两个相继的自限性表面反应。

Molecular Layer Deposition of Polymers

Atomic layer deposition meets various needs including semiconductor device miniaturization and nanoparticle coating.

N V Larionova et al.
International journal of pharmaceutics, 189(2), 171-178 (1999-10-28)
The objective of this study is to demonstrate the feasibility of microcapsules containing a protein and a proteinase inhibitor in order to allow the oral administration of proteic or peptidic drug. Starch/bovine serum albumin mixed-walled microcapsules were prepared using interfacial
D Hettler et al.
Journal of microencapsulation, 11(2), 213-224 (1994-03-01)
Microcapsules were prepared from three proteins, namely human serum albumin (HSA), bovine fibrinogen and ovalbumin, by an interfacial crosslinking process using terephthaloylchloride. They were further treated with alkaline hydroxylamine in order to disrupt ester and anhydride bonds in the walls.
N Pariot et al.
International journal of pharmaceutics, 211(1-2), 19-27 (2001-01-04)
Microcapsules were prepared by interfacial cross-linking of beta-cyclodextrins (beta-CD) with terephthaloyl chloride (TC). Batches were prepared from beta-CD solutions in 1 M NaOH, using 5% TC and a 30 min reaction time. Microcapsules were studied with respect to morphology (microscopy)
查看所有相关文献

全球贸易项目编号

货号GTIN
120871-1KG04061825590967
120871-250G04061838716651
120871-5G04061831828214